rs78054962

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The ENST00000892608.1(INTS13):​c.-387A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0058 in 152,634 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0057 ( 12 hom., cov: 32)
Exomes 𝑓: 0.023 ( 0 hom. )

Consequence

INTS13
ENST00000892608.1 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.523

Publications

1 publications found
Variant links:
Genes affected
INTS13 (HGNC:20174): (integrator complex subunit 13) Involved in regulation of mitotic cell cycle. Acts upstream of or within centrosome localization; mitotic spindle organization; and protein localization to nuclear envelope. Located in cytoplasm and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]
FGFR1OP2 (HGNC:23098): (FGFR1 oncogene partner 2) Predicted to enable identical protein binding activity. Predicted to be involved in response to wounding. Predicted to act upstream of or within wound healing. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000892608.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00575 (874/152102) while in subpopulation EAS AF = 0.0345 (178/5160). AF 95% confidence interval is 0.0304. There are 12 homozygotes in GnomAd4. There are 541 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000892608.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INTS13
NM_018164.3
MANE Select
c.-387A>G
upstream_gene
N/ANP_060634.2Q9NVM9-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INTS13
ENST00000892608.1
c.-387A>G
5_prime_UTR
Exon 1 of 17ENSP00000562667.1
INTS13
ENST00000892611.1
c.-387A>G
5_prime_UTR
Exon 1 of 17ENSP00000562670.1
INTS13
ENST00000946631.1
c.-387A>G
5_prime_UTR
Exon 1 of 17ENSP00000616690.1

Frequencies

GnomAD3 genomes
AF:
0.00576
AC:
875
AN:
151984
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00524
Gnomad ASJ
AF:
0.00952
Gnomad EAS
AF:
0.0344
Gnomad SAS
AF:
0.00436
Gnomad FIN
AF:
0.0414
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00160
Gnomad OTH
AF:
0.00527
GnomAD4 exome
AF:
0.0226
AC:
12
AN:
532
Hom.:
0
Cov.:
0
AF XY:
0.0230
AC XY:
8
AN XY:
348
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
4
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4
European-Finnish (FIN)
AF:
0.0331
AC:
12
AN:
362
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
144
Other (OTH)
AF:
0.00
AC:
0
AN:
14
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00575
AC:
874
AN:
152102
Hom.:
12
Cov.:
32
AF XY:
0.00727
AC XY:
541
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41506
American (AMR)
AF:
0.00523
AC:
80
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00952
AC:
33
AN:
3468
East Asian (EAS)
AF:
0.0345
AC:
178
AN:
5160
South Asian (SAS)
AF:
0.00416
AC:
20
AN:
4812
European-Finnish (FIN)
AF:
0.0414
AC:
438
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00160
AC:
109
AN:
67972
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
47
93
140
186
233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00257
Hom.:
3
Bravo
AF:
0.00331
Asia WGS
AF:
0.0190
AC:
67
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
15
DANN
Benign
0.81
PhyloP100
0.52
PromoterAI
0.0032
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs78054962;
hg19: chr12-27091104;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.